Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes

J.T. Jonker, Y.N. Wang, W. de Haan, M. Diamant, L.J. Rijzewijk, R.W. van der Meer, H.J. Lamb, J.T. Tamsma, A. de Roos, J.A. Romijn, P.C.N. Rensen, J.W.A. Smit

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1625-1628
JournalDiabetes Care
Volume33
Issue number7
DOIs
Publication statusPublished - 2010

Cite this

Jonker, J. T., Wang, Y. N., de Haan, W., Diamant, M., Rijzewijk, L. J., van der Meer, R. W., ... Smit, J. W. A. (2010). Pioglitazone Decreases Plasma Cholesteryl Ester Transfer Protein Mass, Associated With a Decrease in Hepatic Triglyceride Content, in Patients With Type 2 Diabetes. Diabetes Care, 33(7), 1625-1628. https://doi.org/10.2337/dc09-1935